Immix Biopharma Inc (IMMX) stock news · rev $20.0M
Immix Biopharma Inc (IMMX) is a biotechnology company listed on US.
This IMMX news page leads with what Immix Biopharma Inc filed — not a scraped headline mill.
No cached 8-K sentence for IMMX yet. We will not pad this page with generic market recap.
Latest reported IMMX revenue for 2022-12-08 was $20.0M. IMMX currently screens at market cap $640.7M.
EDGAR remains the official archive. Lician caches the exhibit so you can read what changed without a wire story.
Not investment advice. For the model open the IMMX stock page; for the tape open the quote page.
IMMX stock news FAQ
What is IMMX's latest revenue?
Latest cached Immix Biopharma Inc (IMMX) revenue for Dec 8, 2022 was $20.0M. Statements: https://lician.com/financials/immx
What is IMMX's market cap?
Immix Biopharma Inc (IMMX) market cap is $640.7M on the latest cached fundamentals snapshot.
What kind of company is IMMX?
Immix Biopharma Inc (IMMX) is a biotechnology company listed on US.
Where is IMMX stock news listed?
Cached stock news for Immix Biopharma Inc (IMMX) is listed at https://lician.com/news/immx. Filings: https://lician.com/sec/immx
Not investment advice.